Find a Trial Find Expert Physicians 
News Trial Stats
Clinical TrialsFacts & Fears Who pays for it, placebos, being a guinea pig, and what taking part really means.Basics ofTheranostics A fundamental way of finding and treating your cancer, all in one.Basics ofRadiation What is radiation, and how can it benefit you? InterpretingYour Scans What CT, MRI and PET can and can’t tell you about cancer.What to Expect as aTheranostic Patient Scans, treatment day, and the precautions once you are home.Basics ofDosimetry How much radiation each organ and tumor actually absorbs.TheranosticDictionary Plain-language meanings for the vocabulary on your paperwork.
News Trial StatsDark mode
Contact XCancer®
Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT05558956
Total Body PET-CT Imaging of Prostate Cancer Using Illuccix
Overview
Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.
Sponsor
GE Healthcare
Phase
Early Phase 1
Contacts
Dan Rogers (CONTACT)
clinical.research@bamfhealth.com
616-330-3886
ClinicalTrials.gov
NCT05558956Drug / Compound
PSMA-11
Isotope(s):
GALLIUM-68
Radioisotope: Ga-68
Theranostic Role: PET Imaging
T1/2 (Half-Life): 68 minutes
Decay Mode: POSITRON β+ (88.9%), GAMMA, ELECTRON CAPTURE (8.7%)
Energy: Beta: max 1.9 MeV Gamma 1.1 MeV, 511 keV
Range: N/A
Decay Daughters: Zn68 (Stable)
Status: FDA Approvals: NETSPOT® (2016), LOCAMETZ® (2022), ILLUCIX® (2021)
Target(s):
- PSMA
Ligand Class: Small Molecules
Chelator: HBED-CC
Eligibility
Inclusion
- Patients with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
- Patients with suspected metastasis who are candidates for initial definitive therapy
- Patients meeting clinical need for Illuccix PET scan:
- Patient is physically able to lay flat for the PET-CT procedure
Exclusion
- 1\. Assessment by the Investigator as unable or unwilling to comply with the requirements of the protocol.
Share your feedback
Help us improve your experience